TY  - CHAP
AU  - Christoph Metzner
AU  - John Dangerfield
ED  - Ke Xu
Y1  - 2011-07-20
PY  - 2011
T1  - Surface Modification of Retroviral Vectors for Gene Therapy
N2  - The development of technologies that allow targeting of specific cells has progressed substantially in recent years for several types of vectors, particularly viral vectors, which have been used in 70% of gene therapy clinical trials. Particular viruses have been selected as gene delivery vehicles because of their capacities to carry foreign genes and their ability to efficiently deliver these genes associated with efficient gene expression. This book is designed to present the most recent advances in viral gene therapy
BT  - Viral Gene Therapy
SP  - Ch. 3
UR  - https://doi.org/10.5772/20568
DO  - 10.5772/20568
SN  - 
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-24
ER  -